Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Cancer-secreted AGR2 induces programmed cell death in normal cells.

Vitello EA, Quek SI, Kincaid H, Fuchs T, Crichton DJ, Troisch P, Liu AY.

Oncotarget. 2016 Aug 2;7(31):49425-49434. doi: 10.18632/oncotarget.9921.

2.

Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming.

Borges GT, Vêncio EF, Quek SI, Chen A, Salvanha DM, Vêncio RZ, Nguyen HM, Vessella RL, Cavanaugh C, Ware CB, Troisch P, Liu AY.

J Cell Physiol. 2016 Sep;231(9):2040-7. doi: 10.1002/jcp.25313. Epub 2016 Feb 4.

PMID:
26773436
3.

Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.

Pascal LE, Vêncio RZ, Page LS, Liebeskind ES, Shadle CP, Troisch P, Marzolf B, True LD, Hood LE, Liu AY.

BMC Cancer. 2009 Dec 18;9:452. doi: 10.1186/1471-2407-9-452.

4.

Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7. doi: 10.1073/pnas.0813371106. Epub 2009 Feb 25.

5.

Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL.

Wu Z, Jia X, de la Cruz L, Su XC, Marzolf B, Troisch P, Zak D, Hamilton A, Whittle B, Yu D, Sheahan D, Bertram E, Aderem A, Otting G, Goodnow CC, Hoyne GF.

Immunity. 2008 Dec 19;29(6):863-75. doi: 10.1016/j.immuni.2008.11.004.

6.

SLIMarray: lightweight software for microarray facility management.

Marzolf B, Troisch P.

Source Code Biol Med. 2006 Oct 26;1:5.

Supplemental Content

Loading ...
Support Center